HFM Investment Advisors, LLC
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 2067972
GLASSBORO, NJ
Position in AMRX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$415
+$304 QoQ
Shares Held
24
+166.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#287
of 305 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HFM Investment Advisors, LLC holds $15,496 across 11 Drug Manufacturers - Specialty & Generic names. AMRX ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
8 | $4,334 | |
| 2 | VTRS |
Viatris Inc
|
182 | $2,890 | |
| 3 | ZTS |
Zoetis Inc.
|
27 | $1,940 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
75 | $1,845 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
10 | $1,685 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
8 | $887 | |
| 7 | ALKS |
Alkermes plc.
|
16 | $838 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
24 | $415 |
All Filings in AMRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $415 | 24 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $111 | 9 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $113 | 9 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $90 | 9 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $72 | 9 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $16 | 2 | Shares | Sole | 2025-05-16 | |
| No filing history on record for this holder in this stock. | ||||||